Coronavirus Knocks Drug Pricing Down – But Not Off – Political Priority List In US

When the top US health official testified before Congress on the budget this past week, drug pricing was barely discussed. What a difference two weeks – and global spread of a novel infectious disease – makes.

Concept image for illustration of priorities
Coronovirus is taking attention away from drug pricing in US congressional hearings, but is also bringing visibility to the supply chain and national security issues. • Source: Shutterstock

More from Market Access

More from Pink Sheet